Exercise training as an adjunct to orlistat therapy reduces oxidative stress in obese subjects

被引:23
作者
Ozcelik, O [1 ]
Ozkan, Y
Karatas, F
Kelestimur, H
机构
[1] Firat Univ, Fac Med, Dept Physiol, Elazig, Turkey
[2] Firat Univ, Fac Med, Dept Endocrinol & Metab Dis, Elazig, Turkey
[3] Firat Univ, Fac Chem, Elazig, Turkey
关键词
obesity; body mass index; MDA; orlistat; exercise;
D O I
10.1620/tjem.206.313
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OZCELIK, O., OZKAN, Y., KARATAS, F. and KELESTIMUR, H. Exercise Training as an Adjunct to Orlistat Therapy Reduces Oxidative Stress in Obese Subjects. Tohoku J. Exp. Med., 2005, 206 (4), 313-318 - The anti-obesity drug orlistat promotes weight loss and improves obesity-related risk factors, but its effect on oxidative stress is not clear yet. Orlistat reduces dietary fat absorption, which may have effects on fat soluble vitamins especially the antioxidant vitamins A and E. The aim of this study was to determine and compare the effects of weight loss achieved by orlistat therapy and a combination of orlistat with aerobic exercise training on lipid peroxidation and antioxidative defense in obese subjects. Total of 24 obese subjects were randomly assigned to receive 12-week treatment with hypocaloric diet-orlistat (120 mg three times daily) (DO group) or dietorlistat-exercise (DOE group). Serum levels of malondialdehyde (MDA), a marker for lipid peroxidation, and vitamins A and E were measured by high performance liquid chromatography at baseline and at the end of the treatment. Body weight and fat mass were significantly reduced in the two groups (p < 0.001). In the DO group, the MDA levels remained unchanged (p = 0.59), while vitamins A (p < 0.01) and E (p < 0.001) were significantly decreased. In contrast, the subjects treated with DOE exhibited marked decreases in MDA (p = 0.002) and a small but significant decrease in vitamins A (p = 0.003) and E (p = 0.003). Thus, orlistat therapy alone caused a significant reduction in antioxidative capacity without affecting oxidative stress, whereas orlistat in combination with exercise training provided a significant decrease in MDA levels. The beneficial effect of aerobic exercise as an adjunct to the orlistat therapy is of importance with regard to the obesity-associated risk factors. - obesity; body mass index; MDA; orlistat; exercise. (c) 2005 Tohoku University Medical Press.
引用
收藏
页码:313 / 318
页数:6
相关论文
共 31 条
[1]   Orlistat, sibutramine, or combination therapy: Which performs better on waist circumference in relation with body mass index in obese patients? [J].
Aydin, N ;
Topsever, P ;
Kaya, A ;
Karasakal, M ;
Duman, C ;
Dagar, A .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 202 (03) :173-180
[2]   Current and potential drugs for treatment of obesity [J].
Bray, GA ;
Greenway, FL .
ENDOCRINE REVIEWS, 1999, 20 (06) :805-875
[3]   Body-mass index and mortality in a prospective cohort of US adults [J].
Calle, EE ;
Thun, MJ ;
Petrelli, JM ;
Rodriguez, C ;
Heath, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (15) :1097-1105
[4]  
Cerhata D, 1994, Ceska Slov Farm, V43, P166
[5]   OXYRADICALS AND CANCER [J].
CERUTTI, PA .
LANCET, 1994, 344 (8926) :862-863
[6]   Effects of short-period exercise training and orlistat therapy on body composition and maximal power production capacity in obese patients [J].
Colak, R ;
Ozcelik, O .
PHYSIOLOGICAL RESEARCH, 2004, 53 (01) :53-60
[7]   Orlistat - A review of its use in the management of patients with obesity [J].
Curran, MP ;
Scott, LJ .
DRUGS, 2004, 64 (24) :2845-2864
[8]   The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation [J].
Dandona, P ;
Mohanty, P ;
Ghanim, H ;
Aljada, A ;
Browne, R ;
Hamouda, W ;
Prabhala, A ;
Afzal, A ;
Garg, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :355-362
[9]  
DIPLOCK AT, 1991, AM J CLIN NUTR, V53, P189
[10]   Long-term pharmacotherapy of obesity 2000 - A review of efficacy and safety [J].
Glazer, G .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (15) :1814-1824